Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

MMV 390048

Drug Profile

MMV 390048

Alternative Names: MMV 048; MMV390048

Latest Information Update: 07 May 2018

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Griffith University; University of Cape Town
  • Developer Medicines for Malaria Venture; Technology Innovation Agency; University of Cape Town
  • Class Aminopyridines; Antimalarials; Small molecules
  • Mechanism of Action 1-phosphatidylinositol 4-kinase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Phase I/II Malaria

Most Recent Events

  • 21 Apr 2018 Efficacy, adverse events and pharmacokinetic data from two phase Ib trials in Malaria presented at the 28th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID-2018)
  • 02 Feb 2018 Medicines for Malaria Venture withdraws a phase I trial for Malaria (Prevention) in Germany prior to enrolment, for repositioning of target indication (PO) (NCT03195387)
  • 13 Dec 2017 Medicines for Malaria Venture suspends patient enrolment in a phase I trial for Malaria (Prevention) in Germany due to pending analysis of intermediary data (PO) (NCT03195387)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top